BioCentury
ARTICLE | Clinical News

Amplifluor energy transfer nucleic acid detection technology regulatory update

November 6, 2000 8:00 AM UTC

Intergen received U.S. Patents Nos. 6,090,552 and 6,117,986 covering the use of Amplifluor to measure gene expression and telomerase activity, and for in-situ detection of nucleic acids. ...